The orthopedic device giant Stryker has reported a profit of $325 million for the second quarter, up 4.6 percent from the same quarter last year. The device company also reported a 2.9 percent increase in net sales to $2.11 billion, up 2.7 percent from the previous year. Sales related to their neurology and spine business lines saw the greatest growth, increasing 12 percent from the previous year.
More Articles on Stryker:
Stryker Recalls Two Metal Hip Implants
43 Orthopedic & Spine Devices Receive FDA Clearance in May
10 Spine Device Company Executive Moves